
Affinity Capital Management
Description
Affinity Capital Management is a well-established venture capital firm based in Minneapolis, Minnesota, specializing in investments within the healthcare sector. The firm's investment strategy is sharply focused on healthcare technology, encompassing a broad range of sub-sectors including medical devices, diagnostics, healthcare information technology, and healthcare services. With a history spanning several decades, Affinity Capital has cultivated deep expertise and an extensive network within the complex healthcare ecosystem, positioning itself as a strategic partner for innovative companies.
The firm primarily targets companies that are beyond the initial seed stage but have not yet reached profitability, typically engaging in Series B or Series C funding rounds. Affinity Capital seeks businesses with proven technologies, clear market opportunities, and strong, experienced management teams capable of executing their growth strategies. Their investment philosophy emphasizes providing growth capital to help these companies scale operations, expand market reach, and navigate regulatory pathways. The firm manages over $200 million in capital across multiple funds, indicating their capacity to support significant growth initiatives.
Affinity Capital's typical first cheque size ranges from approximately $2 million to $10 million, reflecting their focus on providing substantial growth equity to developing healthcare ventures. This capital is often deployed to support product commercialization, clinical trials, or market expansion efforts. To date, Affinity Capital Management has invested in over 30 companies, building a diverse portfolio of healthcare innovators. Beyond financial investment, the firm actively leverages its industry knowledge and connections to provide strategic guidance, operational support, and access to key opinion leaders, aiming to accelerate the success of its portfolio companies.
Investor Profile
Affinity Capital Management has backed more than 42 startups, with 0 new investments in the last 12 months alone. The firm has led 8 rounds, about 19% of its total and boasts 12 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series C, Series B, Series D rounds (top funding stages).
- Majority of deals are located in United States.
- Strong thematic focus on Health Care, Medical Device, Medical.
- Typical check size: $2M – $10M.
Stage Focus
- Series C (29%)
- Series B (21%)
- Series D (19%)
- Series E (10%)
- Series A (10%)
- Series Unknown (10%)
- Series F (2%)
Country Focus
- United States (100%)
Industry Focus
- Health Care
- Medical Device
- Medical
- Biotechnology
- Therapeutics
- Health Diagnostics
- Developer Platform
- Clinical Trials
- Wireless
- Information Technology
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.